Glipizide and Zelboraf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glipizide (glipizide) and Zelboraf (vemurafenib). Common drug interactions include rash among females and alopecia among males.

The phase IV clinical study analyzes what interactions people have when they take Glipizide and Zelboraf. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Zelboraf?

Zelboraf has active ingredients of vemurafenib. eHealthMe is studying from 8,392 Zelboraf users. Check the latest studies of Zelboraf.

On Jul, 20, 2026

14 people who take Glipizide and Zelboraf together, and have interactions are studied.

Glipizide and Zelboraf drug interactions.

What are the common drug interactions of Glipizide and Zelboraf, by gender? *:

female:

Rash
Arthralgia (joint pain)
Fatigue (feeling of tiredness)
Diarrhoea
Alopecia (absence of hair from areas of the body)
Decreased appetite
Headache (pain in head)
Mass
Oedema peripheral (superficial swelling)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

male:

Alopecia (absence of hair from areas of the body)
Arthralgia (joint pain)
Hypoaesthesia (reduced sense of touch or sensation)
Mass
Oedema peripheral (superficial swelling)
Rash
Stomatitis (inflammation of mucous membrane of mouth)
Visual impairment
Asthenia (weakness)
Drug ineffective

What are the common drug interactions of Glipizide and Zelboraf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood glucose increased
Skin discolouration (change of skin colour)

60+:

Fatigue (feeling of tiredness)
Rash
Eye irritation
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Stomatitis (inflammation of mucous membrane of mouth)
Visual impairment
Metastases to lung (cancer spreads to lung)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

What are the existing conditions these people have? *

Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 6 people, 42.86%
Malignant Melanoma (skin cancer rises from melancytes): 4 people, 28.57%
Renal Cell Carcinoma (a kidney cancer): 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 7.14%
Nausea (feeling of having an urge to vomit): 1 person, 7.14%
Hairy Cell Leukaemia (a type of blood cancer): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and Zelboraf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously